๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical course for patients with peritoneal carcinomatosis excluded from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

โœ Scribed by Rodt, Anne; Svarrer, Rebekka; Iversen, Lene

Book ID
121618196
Publisher
BioMed Central
Year
2013
Tongue
English
Weight
175 KB
Volume
11
Category
Article
ISSN
1477-7819

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Cytoreductive surgery and intraperitonea
Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma
โœ Samuel P. Jacks; Jonathan C. Hundley; Perry Shen; Greg B. Russell; Edward A. Lev ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 79 KB

Introduction: Peritoneal carcinomatosis (PC) is associated with a dismal prognosis. Small bowel adenocarcinoma is a rare etiology for PC. Due to the rarity, poor prognosis, and lack of standard treatment, we chose to review our experience with this disease process treated with cytoreductive surgery

Postoperative Infections in Cytoreductiv
Postoperative Infections in Cytoreductive Surgery With Hyperthermic Intraperitoneal Intraoperative Chemotherapy for Peritoneal Carcinomatosis
โœ A. Capone; M. Valle; F. Proietti; O. Federici; A. Garofalo; N. Petrosillo ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 103 KB

## Abstract ## Background Peritoneal carcinomatosis is a common evolution of many abdominal and pelvic malignancies. Over the last decade novel therapeutic approaches have emerged combining cytoreductive surgery with perioperative intraperitoneal chemotherapy. Aim of our study was to assess freque

Results of cytoreductive surgery and hyp
Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer
โœ Gabriel Glockzin; Nabil Ghali; Sven A. Lang; Hans J. Schlitt; Pompiliu Piso ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 168 KB

## Abstract Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) provide a promising additional treatment option for selected patients with peritoneal carcinomatosis arising from colorectal cancer. Due to the aggressive surgery the concept is associated with a significa